GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sansure Biotech Inc (SHSE:688289) » Definitions » 3-Year EBITDA Growth Rate

Sansure Biotech (SHSE:688289) 3-Year EBITDA Growth Rate : -45.60% (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Sansure Biotech 3-Year EBITDA Growth Rate?

Sansure Biotech's EBITDA per Share for the three months ended in Sep. 2024 was ¥0.07.

During the past 12 months, Sansure Biotech's average EBITDA Per Share Growth Rate was -65.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -45.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Sansure Biotech was 220.90% per year. The lowest was -45.60% per year. And the median was 87.65% per year.


Competitive Comparison of Sansure Biotech's 3-Year EBITDA Growth Rate

For the Medical Instruments & Supplies subindustry, Sansure Biotech's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sansure Biotech's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sansure Biotech's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Sansure Biotech's 3-Year EBITDA Growth Rate falls into.



Sansure Biotech 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Sansure Biotech  (SHSE:688289) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Sansure Biotech 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Sansure Biotech's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Sansure Biotech Business Description

Traded in Other Exchanges
N/A
Address
No. 680, Lusong Road, Changsha High-tech Industrial Development Zone, Hunan Province, Changsha, CHN, 410205
Sansure Biotech Inc is engaged in production and sales of diagnostic reagents and instruments. The company produces Class I medical devices, Class II medical devices, Class III medical devices, general instruments and meters, medical raw materials, medical laboratory equipment and appliances, and medical accessories.
Executives
Tan De Yong Core technical personnel
Wang Hai Xiao senior management
Jie Ya Ping Core technical personnel
Zhang Ke Ya Core technical personnel
Yang Li Core technical personnel
Liu Rang Jiao Core technical personnel
Deng Zhong Ping Senior management, core technical personnel
Zhou Jun senior management
Zhu Jian senior management
Wu Kang Core technical personnel
Xiong Xiao Yan senior management
Ji Bo Zhi Core technical personnel
Mou Wei Min Core technical personnel
Ren Xiao Mei Core technical personnel
Liu Kai senior management

Sansure Biotech Headlines

No Headlines